Literature DB >> 1569122

Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli.

C A Midgley1, C J Fisher, J Bártek, B Vojtĕsek, D Lane, D M Barnes.   

Abstract

A cDNA encoding the complete normal human p53 protein was expressed in Escherichia coli using an expression system based on the bacteriophage T7 promoter. The cDNA was adapted so that the full-length protein was produced without fusion to any other sequence. Large amounts of the protein were isolated and the purified protein used to produce very high titre polyclonal antibodies to p53. These new antibodies permit the sensitive detection of p53 and p53 complexes in ELISA and immunoblotting assays. Most importantly, they also permit the detection of p53 in archival tumour material that has been conventionally fixed in formalin and embedded in paraffin wax. Using this reagent we have found that aberrant expression of p53 is a frequent feature of human breast cancer. We are able to recognise six different classes of p53 expression pattern that may be of help in the subclassification of breast tumours.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1569122     DOI: 10.1242/jcs.101.1.183

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  103 in total

1.  Stress signals utilize multiple pathways to stabilize p53.

Authors:  M Ashcroft; Y Taya; K H Vousden
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.

Authors:  M S Rodriguez; J M Desterro; S Lain; D P Lane; R T Hay
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

3.  Role of tumor suppressor p53 domains in selective binding to supercoiled DNA.

Authors:  Marie Brázdová; Jan Palecek; Dmitry I Cherny; Sabina Billová; Miroslav Fojta; Petr Pecinka; Borivoj Vojtesek; Thomas M Jovin; Emil Palecek
Journal:  Nucleic Acids Res       Date:  2002-11-15       Impact factor: 16.971

4.  Involvement of the DNA repair protein hHR23 in p53 degradation.

Authors:  Sandra Glockzin; Francois-Xavier Ogi; Arnd Hengstermann; Martin Scheffner; Christine Blattner
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

5.  Hypophosphorylation of Mdm2 augments p53 stability.

Authors:  Christine Blattner; Trevor Hay; David W Meek; David P Lane
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

6.  p53 protein in odontogenic cysts: increased expression in some odontogenic keratocysts.

Authors:  G R Ogden; D M Chisholm; R A Kiddie; D P Lane
Journal:  J Clin Pathol       Date:  1992-11       Impact factor: 3.411

7.  p53 expression in lymphatic malignancies.

Authors:  Y Soini; P Pääkkö; M Alavaikko; K Vähäkangas
Journal:  J Clin Pathol       Date:  1992-11       Impact factor: 3.411

8.  Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation.

Authors:  H Haapasalo; J Isola; P Sallinen; H Kalimo; H Helin; I Rantala
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

9.  Expression of p53 product in Chinese human bladder carcinoma.

Authors:  D W Ye; J F Zheng; S X Qian; Y J Ma
Journal:  Urol Res       Date:  1993-05

10.  Expression of p53 protein related to human papillomavirus and DNA ploidy in superficial esophageal carcinoma.

Authors:  T Nakamura; H Ide; R Eguchi; K Hayashi; F Hanyu; K Nagasako; M Yukawa; K Asaka; T Fujimori; S Maeda
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.